ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email!
Argentina Pharmaceuticals and Healthcare Report Q4 2011 Published on August 2011
Report Summary BMI View: Argentina's pharmaceutical market, driven by an ageing population and resurgent economic growth, has proven a lucrative stepping stone for pharmaceutical companies looking to penetrate Latin America. While Argentina's President Cristina Fernandez has made healthcare a key election issue, her political rhetoric has largely focused on strengthening the local pharmaceutical sector. We anticipate nationalist threats are likely to increase in the run-up to the 2011 elections, especially as the opposition now control congress. As it stands, government policies ' heavily biased towards local companies, with the authorities keen to keep the national drugs bill low through price controls and state-run laboratories ' do further damage to Argentina's already fragile reputation among international pharmaceutical firms.
Headline Expenditure Projections .. Pharmaceuticals: ARS29.17bn (US$7.46bn) in 2010 to ARS34.19bn (US$8.24bn) in 2011; +17.2% in local currency terms and +10.4% in US dollar terms. Forecast upwards from Q311 due to data overhaul and macroeconomic factors. .. Healthcare: ARS137.20bn (US$35.10bn) in 2010 to ARS157.85bn (US$38.04bn) in 2011; +15.1% in local currency terms and +8.4% in US dollar terms. Forecast up from Q311 due to macroeconomic factors. .. Medical devices: ARS2.74bn (US$698mn) in 2010 to ARS3.19bn (US$768mn) in 2011; +17.0% in local currency terms and +10% in US dollar terms. Forecast up from Q311 due to macroeconomic factors. Business Environment Rating: Argentina retains its fifth place rank in BMI's Business Environment Ratings (BERs) for Q411, having moved to that spot from seventh at the end of 2010. However, its attractiveness on the Rewards side is considerably higher than on the Risk side, which is illustrative of the challenging intellectual property (IP) and pharmaceutical pricing and procurement environments. Nevertheless, we expect Argentina to continue to be viewed with interest by multinational players, although it is unlikely to receive as much investment as its fast growing neighbour Brazil. Key Trends & Developments .. In July 2011, the country's senate unanimously passed a bill to increase production at its staterun pharmaceutical companies. The law makes the provision of accessible and equitable healthcare a national interest and helps the country produce its own drugs, vaccines and medical supplies through 39 state-run manufacturers. The decision was billed as helping the country reduce its reliance on expensive medicine imports, coordinate public medicine production and ultimately meet rising public health demands in a way that is self-sufficient. .. The government has responded to a series of prescription drug scandals by clamping down on over-the-counter (OTC) pharmacy sales. A study by TNS Gallup found that around 60% of Argentines find it more convenient to purchase medicines at retailers other than pharmacies. However, the government is concerned about the increasing number of non-pharmacies illegally selling prescription medicines. In June 2010, Argentina's Drug, Food and Medical Technology Administration (Anmat) responded to the abuses by restricting the sale of OTC drugs. BMI Economic View: The Argentine economy has huge potential on account of its natural resource wealth and highly educated labour force. Over the long term, as the regional economy benefits from an expansion in Asian demand and the Brazilian growth story continues apace, Argentina is better positioned than most to benefit. However, our baseline forecasts see Argentine real GDP growth lagging the region, averaging just 3.6% over the 10-year forecast period, owing to continued government mismanagement of the economy. Indeed, in recent years, expansionary policies, have, in our view, left the economy poised for a period of aneamic growth. Argentina's susceptibility to boom and bust cycles has been evident over the past two decades, with GDP per capita rising the most in the region from 2002 to 2008, but the least since 1993 owing to the 2001-2002 economic crisis and subsequent recession. BMI Political View: Argentina's President Cristina Fernรกndez has selected incumbent Economy Minister Amado Boudou as her
Argentina Pharmaceuticals and Healthcare Report Q4 2011 (From Issuu)
Page 1/6
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! running partner for the forthcoming elections scheduled to be held in October. Fernandez selected Boudou after cutting ties with incumbent Vice President Julio Cobos in 2008 following his disapproval over a proposed rise in agricultural export taxes. Boudou advised the government on the takeover of private pension funds worth around US$24bn that helped boost expenditure in 2008 and managed the debt restructuring of approximately US$12.9bn in 2010. While the crushing defeat of the Kirchners in the mid-term elections in June 2009 suggested that the current Argentine president's all-out expansionary and interventionist policies were wearing thin with the electorate, Fernรกndez has bounced back strongly on the back of the nation's strong economic growth trajectory, and we do not expect a new and more business-friendly government to enter the frame in 2012.
Table of Content Executive Summary 7 SWOT Analysis 9 Argentina Pharmaceuticals And Healthcare Industry SWOT ... 9 Argentina Political SWOT .. 10 Argentina Economic SWOT 11 Argentina Business Environment SWOT . 12 Table: Americas ' Regional Pharmaceutical Business Environment Ratings, Q411 ... 13 Rewards .. 14 Risks ... 15 Argentina ' Market Summary ... 16 Regulatory Regime 18 OTC Regulation .. 19 Recent Regulatory Developments ... 20 Intellectual Property (IP) Environment .. 21 IP Disputes . 23 Counterfeit Pharmaceuticals .. 25 Pricing Regime ... 26 Table Argentina ' Pharmaceutical Price Build-Up 26 Table: Argentina's Drug Price Freeze, 2005-2008 . 28 Reimbursement Regime ... 29 Other Regulatory Issues .. 29 Industry Trends And Developments 31 Epidemiology .. 31 Communicable Disease ... 32 Healthcare System .. 33 Healthcare Insurance . 34 Medical Tourism . 35 Medicinal Plants . 36 Table Argentina ' Imports of Medicinal Plants by Country (US$'000) ... 36 Research and Development (R&D) . 36 Clinical Trials . 38 Medical Devices.. 39 Industry Forecast Scenario ... 41 Overall Market Forecast. 41
Argentina Pharmaceuticals and Healthcare Report Q4 2011 (From Issuu)
Page 2/6
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! Table: Pharmaceutical Sales Indicators 2007-2015 ... 42 Key Growth Factors ' Industry... 43 Table: Healthcare Expenditure Indicators 2007-2015 44 Key Growth Factors ' Macroeconomic .. 45 Table: Argentina ' Economic Activity 49 Prescription Drug Market Forecast 50 Table: Argentina Prescription Drug Market, Historical Data and Forecasts .. 51 Patented Drug Market Forecast . 52 Table: Argentina Patented Drug Market, Historical Data and Forecasts ... 53 Generic Drug Market Forecast ... 54 Argentina Pharmaceuticals & Healthcare Report Q4 2011 漏 Business Monitor International Ltd Page 4 Table: Argentina Generic Drug Market, Historical Data and Forecasts . 55 OTC Medicine Market Forecast . 56 Table: Argentina OTC Market, Historical Data and Forecasts ... 59 Medical Device Market Forecast 60 Table: Argentina Medical Devices Market, Historical Data and Forecasts 61 Table: Argentina Pharmaceuticals Trade, Historical Data and Forecasts .. 64 Other Healthcare Forecasts 64 Key Risks To BMI's Forecast Scenario ... 65 Competitive Landscape 66 Pharmaceutical Industry . 66 Domestic Pharmaceutical Sector 66 Foreign Pharmaceutical Sector .. 68 Recent Company Developments .. 69 Vaccines Sector ... 71 Recent Developments in the Vaccines Sector .. 73 Pharmaceutical Wholesale Sector .. 73 Retail Pharmacy Sector .. 74 Company Monitor .. 76 Local Manufacturers 76 Laboratorios Roemmers.. 76 Laboratorios Bag贸 .. 78 Leading Foreign Companies 81 Pfizer .. 81 Roche .. 83 Novartis .. 85 GlaxoSmithKline (GSK) .. 87 Sanofi-Aventis . 89 Merck & Co 91 Boehringer Ingelheim . 93 Country Snapshot: Argentina Demographic Data .. 95 Section 1: Population .. 95 Table: Demographic Indicators, 2005-2030 ... 95 Table: Rural/Urban Breakdown, 2005-2030 .. 96 Section 2: Education And Healthcare . 96 Table: Education 96 Table: Life Expectancy, 2005-2030 96
Argentina Pharmaceuticals and Healthcare Report Q4 2011 (From Issuu)
Page 3/6
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! Section 3: Labour Market And Spending Power . 97 Table: Employment Indicators, 2001-2006 . 97 Table: Consumer Expenditure, 2000-2012 (US$) ... 97 Table: Average Annual Manufacturing Wages, 1995-2001 98 Glossary . 99 BMI Methodology 101 How We Generate Our Pharmaceutical Industry Forecasts ...101 Pharmaceuticals Business Environment Ratings 102 Risk/Reward Ratings Methodology 102 Ratings Overview ...102 Table: Pharmaceutical Business Environment Indicators .103 Argentina Pharmaceuticals & Healthcare Report Q4 2011 Š Business Monitor International Ltd Page 5 Weighting ...104 Table: Weighting Of Components ..104 Sources ..104
Argentina Pharmaceuticals and Healthcare Report Q4 2011 (From Issuu)
Page 4/6
Find Industry reports, Company profiles and Market Statistics
ReportLinker
>> Get this Report Now by email! Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to: ƒ ƒ
Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information Please verify that the product information is correct and select the format(s) you require. Argentina Pharmaceuticals and Healthcare Report Q4 2011
Product Formats Please select the product formats and the quantity you require.
Digital Copy--USD 530.00
Quantity: _____
Contact Information Please enter all the information below in BLOCK CAPITALS
Title:
Mr
Mrs
Dr
Miss
Ms
Prof
First Name:
_____________________________ Last Name: __________________________________
Email Address:
__________________________________________________________________________
Job Title:
__________________________________________________________________________
Organization:
__________________________________________________________________________
Address:
__________________________________________________________________________
City:
__________________________________________________________________________
Postal / Zip Code:
__________________________________________________________________________
Country:
__________________________________________________________________________
Phone Number:
__________________________________________________________________________
Fax Number:
__________________________________________________________________________
Argentina Pharmaceuticals and Healthcare Report Q4 2011 (From Issuu)
Page 5/6
Find Industry reports, Company profiles and Market Statistics
ReportLinker
>> Get this Report Now by email! Payment Information Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card
Card Number: ______________________________________________
Expiry Date
__________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer
Crédit Mutuel RIB : 10278 07314 00020257701 89 BIC : CMCIFR2A IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check
UBIQUICK SAS 16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at http://www.reportlinker.com/index/terms
Please fax this form to: Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
Argentina Pharmaceuticals and Healthcare Report Q4 2011 (From Issuu)
Page 6/6